Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
8.51
-0.36 (-4.06%)
At close: May 29, 2026, 4:00 PM EDT
8.67
+0.16 (1.88%)
After-hours: May 29, 2026, 6:08 PM EDT
Bioventus Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 576.3 | 568.09 | 573.28 | 512.35 | 512.12 | 430.9 | |
Revenue Growth (YoY) | 1.52% | -0.91% | 11.89% | 0.04% | 18.85% | 34.17% |
Cost of Revenue | 180.43 | 179.93 | 185.05 | 184.15 | 181.04 | 128.19 |
Gross Profit | 395.87 | 388.16 | 388.23 | 328.19 | 331.08 | 302.71 |
Selling, General & Admin | 318.85 | 314.03 | 343.8 | 303.88 | 332.13 | 254.25 |
Research & Development | 11.57 | 12.11 | 13.95 | 13.45 | 23.85 | 19.04 |
Other Operating Expenses | 2.69 | 2.32 | 38.02 | 83.75 | 132.58 | 8.99 |
Total Operating Expenses | 333.11 | 328.46 | 395.77 | 401.08 | 488.57 | 282.28 |
Operating Income | 57.52 | 53.98 | -15.2 | -81.73 | -167.23 | 12.06 |
Interest Expense | -23.3 | -26.49 | -38.79 | -40.68 | -12.02 | -1.11 |
Other Non-Operating Income (Expense) | -16.16 | -27.14 | -38.79 | -40.68 | -12.02 | -1.11 |
Total Non-Operating Income (Expense) | -39.46 | -53.62 | -77.58 | -81.35 | -24.04 | -2.22 |
Pretax Income | 33.64 | 25.71 | -52.34 | -121.11 | -189.03 | 9.49 |
Provision for Income Taxes | -0.9 | -1.57 | -5.29 | 0.09 | -44.37 | -1.97 |
Net Income | 28.48 | 22.73 | -36.13 | -156.23 | -158.7 | 19.38 |
Minority Interest in Earnings | 6.06 | 4.54 | -10.92 | -39.4 | -54.69 | -9.79 |
Earnings From Discontinued Operations | - | - | - | 74.43 | 68.74 | 1.87 |
Net Income to Common | 28.48 | 22.73 | -36.13 | -156.23 | -158.7 | 19.38 |
Net Income Growth | - | - | - | - | - | 18.06% |
Shares Outstanding (Basic) | 16,805 | 67 | 65 | 63 | 61 | 45 |
Shares Outstanding (Diluted) | 17,367 | 69 | 65 | 63 | 61 | 45 |
Shares Change (YoY) | 26539.15% | 6.77% | 3.03% | 2.05% | 35.00% | -11.70% |
EPS (Basic) | 0.43 | 0.34 | -0.56 | -2.49 | -2.59 | -0.15 |
EPS (Diluted) | 0.41 | 0.33 | -0.56 | -2.49 | -2.59 | -0.15 |
Shares Outstanding | 67.64 | 67.1 | 65.76 | 63.27 | 62.06 | 59.55 |
Free Cash Flow | 100.63 | 72.11 | 37.79 | 7.98 | -15.02 | 9.47 |
Free Cash Flow Growth | 39.55% | 90.83% | 373.43% | - | - | -82.85% |
Free Cash Flow Per Share | 0.01 | 1.05 | 0.59 | 0.13 | -0.24 | 0.21 |
Gross Margin | 68.69% | 68.33% | 67.72% | 64.06% | 64.65% | 70.25% |
Operating Margin | 9.98% | 9.50% | -2.65% | -15.95% | -32.66% | 2.80% |
Profit Margin | 5.99% | 9.60% | -16.41% | -61.84% | -69.91% | 4.88% |
FCF Margin | 17.46% | 12.69% | 6.59% | 1.56% | -2.93% | 2.20% |
EBITDA | 103.87 | 100.99 | 34.36 | -24.36 | -111.84 | 46.94 |
EBITDA Margin | 18.02% | 17.78% | 5.99% | -4.75% | -21.84% | 10.89% |
EBIT | 57.52 | 53.98 | -15.2 | -81.73 | -167.23 | 12.06 |
EBIT Margin | 9.98% | 9.50% | -2.65% | -15.95% | -32.66% | 2.80% |
Effective Tax Rate | -2.67% | -6.09% | 10.11% | -0.07% | 23.48% | -20.72% |